Antidote competitors

Antidote's competitors include Mast Therapeutics, Sucampo Pharmaceuticals, BTG and Zogenix
Add company...
Antidote
Antidote is accelerating the breakthroughs of new treatments by bridging the gap between medical research and the people who need them.
Mast Therapeutics
A San Diego-based biopharmaceutical company.
Sucampo Pharmaceuticals
Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.
BTG
BTG is an international specialist healthcare company.
Zogenix
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
Founding Date
Founding Date
2009
Founding Date
1995
Founding Date
1996
Founding Date
1948
Founding Date
2006
Type
Type
Private
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
London, GB HQ
New York, US
Carmel, US
Locations
San Diego, US HQ
Locations
Rockville, US HQ
Kita Ward, JP
Chiyoda, JP
Chuo Ward, JP
Sanda Shi, JP
Zug, CH
Milton, GB
Locations
London, GB HQ
Rosedale, AU
Ottawa, CA
Düsseldorf, DE
Hong Kong , HK
Ataşehir, TR
Surrey, GB
see more
Locations
Emeryville, US HQ
Windsor And Maidenhead, GB
Employees
Employees
671% decrease
Employees
14133% increase
Employees
139
Employees
1,355
Employees
67
Valuation ($)
Valuation ($)
N/A
Valuation ($)
358.7 m
Valuation ($)
1.2 b
Valuation ($)
3.9 b
Valuation ($)
1.7 b
Facebook likes
Facebook likes
104 k
Facebook likes
310
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
N/A
Twitter followers
Twitter followers
1
Twitter followers
873
Twitter followers
242
Twitter followers
786
Twitter followers
475

Financial

Revenue (est.)
Revenue (est.)
£2.4m (FY, 2016)
Revenue (est.)
N/A
Revenue (est.)
$230.1m (FY, 2016)
Revenue (est.)
£620.5m (FY, 2018)
Revenue (est.)
$9.8m (FY, 2017)
Cost of goods
Cost of goods
£1.1m (FY, 2016)
Cost of goods
N/A
Cost of goods
$76m (FY, 2016)
Cost of goods
£185.9m (FY, 2018)
Cost of goods
$10.7m (FY, 2017)
Gross profit
Gross profit
£1.3m (FY, 2016)
Gross profit
N/A
Gross profit
$154.1m (FY, 2016)
Gross profit
£434.6m (FY, 2018)
Gross profit
($908k) (FY, 2017)
Net income
Net income
(£3.3m) (FY, 2016)
Net income
($29.8m) (FY, 2017)
Net income
$18.5m (FY, 2016)
Net income
£12.7m (FY, 2018)
Net income
($126.8m) (FY, 2017)
For sources of this data, please see the company profileDownload Excel

View company profiles

Mast Therapeutics
HQ
San Diego, US
Employees
14

A San Diego-based biopharmaceutical company.

View company
Sucampo Pharmaceuticals
HQ
Rockville, US
Employees
139

Sucampo is a global biopharmaceutical company focused on the development and commercialization of medicines based on prostones, to meet the major unmet medical needs of patients on a global basis.

View company
BTG
HQ
London, GB
Employees
1,355

BTG is an international specialist healthcare company.

View company
Zogenix
HQ
Emeryville, US
Employees
67

Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.

View company